GUIDE TO NEWBORN SCREENING PROGRAMME
|
|
- Ann Walters
- 5 years ago
- Views:
Transcription
1 \ GUIDE TO NEWBORN SCREENING PROGRAMME 1
2 MEDILAB PROFILE MEDILAB, the leading independent provider of Clinical Laboratory Diagnostic Services in Cyprus, was established in 1980 by Mr. C. Pavlides and has grown since steadily over the years to become the largest Laboratory Services by providing an extensive range of high quality routine and specialised laboratory referral investigations to meet all the needs of the medical specialists. MEDILAB has been the laboratory of choice for the majority of the medical community in Cyprus and the pioneer in the application of the most advanced technologies and methodologies, including the Newborn Screening Programme. MEDILAB, is considered today amongst the most Accredited Laboratories in Europe, having been accredited by the European and International Accreditation Certificate ISO15189 in over 170 tests, covering all major disciplines, including that of Clinical Microbiology. MEDILAB s reputation was built on Quality and Modern Technology, coupled by its timely and continuous improvement in its services, fast turnaround of results, most within 2 hrs, low cost, efficient management and continuous innovation. MEDILAB is considered by the medical community as the most state of the art technologically and electronically advanced Laboratory in Cyprus, equipped with cutting edge technology, capable of performing up to 8000/tests per day. Efficiency backed by the use of modern LIS, along with the newest electronic equipment in fields such as OCR technology, for automatic test ordering and for patient registration, results transmission by various ways, including HL7 protocol etc. MEDILAB operates from its owner-occupied and luxurious 600m 2 premises in a modern Laboratory setting situated in the Lycavittos area in Nicosia. Our in-house team is composed of 22 well trained professionals, operating its own courier service, home phlebotomy service and an exclusive 24 hour on call service. MEDILAB s popular Referral Services provides a comprehensive specialty diagnostic service to over 130 Laboratories, Private Hospitals, Medical Centres and Government Hospitals. Costas Pavlides, MRSC, FIBMS Medilab Director 2
3 NEWBORN SCREENING PROGRAMME Medilab offers the Newborn Screening Programme, an innovative test that screens babies at birth for 54 Inborn Errors of Metabolism (IEM). The Newborn Screening Programme is performed under the strict international standards, fully in line with modern scientific practices in the field of Paediatric Prevention. The implementation of the Programme, can save lives or prevents severe psychokinetic disabilities. The purpose of the Programme is to detect diseases in newborns in the first few days of life, for which early medical intervention leads to reduction or elimination of mortality, pathology or general health complications of the newborn. The Programme applies to the whole neonatal population and the process is quite simple: around the 2nd to 6th day of birth a few drops of blood are collected on a special collection card (Guthrie), are tested for IEM with results made available within 2-4 days from sample arrival at the Laboratory. If the child is born with a disorder and does not receive proper treatment early, this is likely to lead to severe long-term health complications, such as physical and mental retardation, neurokinetic disorders or even premature death. In most cases, treatment is very simple and it involves either avoiding certain foods or supplementing food with some hormones or vitamins. One by one the disorders may be rare, but all together the Inborn Errors of Metabolism are frequent with rates ranging from 1:1000 to 1:5000. Our specialized laboratory applies state-of-the-art technology and methodologies, according to the standards proclaimed by the American College of Medical Genetics. Quality certified by Accreditation under the European and International Quality Standard ISO 15189, with an applied External Quality Control under the strictest specifications of the European Union and the U.S. Newborn screening Programmes are widely applied in all developed countries around the globe since Each country chooses a customized panel of tests, according to its history of inherited diseases, economic strength and pressure applied by each country s scientific lobby. In the U.S.A all the states apply Newborn Screening Programme with a panel of tests varying, reaching in some states up to 75 disorders. 3
4 Medilab is ready, strengthened by its sound structure, the expertise, the capacity and the logistics, to undertake in the event of a concord, the screening of all the country s newborn babies. Furthermore, by using the detailed data & information that are collected from all newborns, we will help in the establishment, or strengthening if already exists, a National Epidemiology & Hereditary Diseases for your country. Such detailed data can help to create a Preventive Health Policy, as dictated by the modern international scientific practices in Pediatrics Prevention. Kind Regards,... Costas Pavlides, MRSC, FIBMS Medilab Director 4
5 EXPANDED NEWBORN SCREENING PROGRAMME CLINICAL APPLICATION: PROGNOSIS USEFULNESS & BENEFITS A- The Programme 1. Our Expanded Newborn Programme tests for 54 Inborn Errors of Metabolism (IEM) in a drop of blood on the Guthrie paper. 2. Results in 2-4 days from the time the sample arrives at the Lab. 3. Free follow up tests in children who test positive on the screening test, with specialized analysis for metabolic tests. B- Newborn Testing Prevention Policy 1. Prevents the birth of a second child with IEM. Parents who have no family history of problems and/or who have already had healthy children can still have children with these disorders. 2. Most infants with these disorders show no signs of these conditions. If these conditions are detected at birth the child can lead a normal, healthy life. 3. Application of the programme will prevent the birth of children with permanent disabilities thus relieving, both the family and the state, of the huge psychological and life economic burden for the treatment and rehabilitation of these children in costly specialized Medical Centres. 4. Contribution to the shaping of a State Health Prevention Policy. C- Epidemiology 1. Archive for epidemiology statistical studies for the prevention and epidemiology of hereditary diseases. 2. Results data will be useful to the government to help draw conclusions regarding prevention measures and epidemiological prevalence of the various diseases and apply new approach to therapy. Such data are also welcomed by the European Union. 5
6 D- Test and Method Credentials 1. Quality Assurance The laboratory participates in all Quality Control (QC) programs performed internationally on the subject such as the Centre for Disease Control CDC (Atlanta USA), ERNDIM (UK based) etc. 2. Accreditation The Laboratory is an ISO Accredited specifically for newborn screening methodologies. 3. Application of modern technology according to strict standards of American College of Medical Genetics. 4. Logistics Organizational structure and logistics in place, for a rapid transportation of samples to Medilab Laboratories. 5. Electronic transmission of results, possible application of remote access. E- Medilab Commitment 1. To provide results of the Expanded Newborn Programme of 54 Inborn Errors of Metabolisms (IEM) 2. To analyze the tests included in the Program based on internationally accepted analytical standard methods. 3. To provide free of charge the Guthrie collection filter papers in English, Greek and Russian language. 4. To undertake shipping expenses for the samples sent to Medilab. 5. To provide free of charge tests to confirm positive screening results. 6. To results as soon they are completed. 6
7 THE NEWBORN PROGRAMME SCREENING Testing for 54 Inborn Errors of Metabolism (IEM) Q. What is the Newborn Screening Programme? Newborn Screening Programme tests babies for serious disorders, usually performed when the baby is 2-4 days old Q. Why is Newborn Screening Programme done? It is done to find out if the baby has a disease or condition for which early treatment can prevent death, mental retardation, or physical disability. Q. How is performed? Newborn Screening Programme is performed by pricking the baby s heel and putting a few drops of blood on the Guthrie special filter paper. The paper is allowed to dry and then sent to the laboratory Q. But we have no family history of these disorders... Parents who have no family history of problems and/or who have already had healthy children can still have children with these disorders. In fact, most children with these disorders come from families with no previous history of the condition. Genes for these disorders can be passed along through generations of healthy people. These "carriers" are healthy because the normal gene in the pair is working (genes come in pairs one from each parent), making up for the flawed gene. But when two people who coincidently carry the same flawed gene get together, their risk of having an affected child is 25% for each pregnancy. This pattern called recessive inheritance, explains how most metabolic diseases appear unexpectedly. Q. But my baby looks healthy... Most babies with disorders look and act normal and seem perfectly healthy. The Newborn Screening Programme helps to catch the problem before symptoms and before the baby becomes sick. If babies are diagnosed and treated early they do well and lead a healthy life. The earlier the disorder is detected, the higher the chance of having a good prognosis. Q. What is a Retest? If the result of your child's test is abnormal, a "retest" is usually required. A request for a retest does not necessarily mean the child has a disorder, but that it is possible. 7
8 Q. What does a positive result indicate? Parents should not be alarmed by positive results as the screening gives only preliminary information, albeit with a high degree of accuracy. In this case, Newborn Screening Test should be followed by a precise confirmatory test. Q. What exactly are Inborn Errors of Metabolism (IEM)? These are disorders caused by the accumulation of chemicals produced naturally in the body to abnormal levels. The symptoms manifest themselves in a variety of ways; slow physical development or mental retardation. In some cases, they could result in death. Unfortunately, most newborns with these disorders show no signs of these conditions. If these conditions are detected at birth, the child can be treated and lead a normal, healthy life. Q. If the disorder is detected early can it save lives? What the therapy consists of? Of course Newborn Screening Programme can save lives or prevent serious psychokinetic disabilities. The symptoms and effects can be mitigated, if they are detected and treated early, leading to a normal life. Therapy in most cases consists of special diets such as, reduction of fat, reduction of proteins, treatment with certain amino acids etc Without therapy the disorder is fatal and if not so, it can result in severe psychokinetic retardation, causing family and the state, huge psychological and life economic burden for the treatment and rehabilitation of these children in costly specialized Medical Centres. Q. Can Newborn Screening Test be performed in older children or adults? Yes. Older children or adults can also be screened but without the test for Cystic Fibrosis. Q. Will Newborn Screening Test detect all conditions? The analyses conducted produce results that can be used by qualified physicians in the diagnosis of IEMs. Evidence of these conditions will be detected in the vast majority of affected individuals. However, due to genetic variability, age of the patient at the time of specimen collection, quality of the specimen, health status of the patient and other variables, such conditions may not be detected in all. 8
9 FREQUENCY OF INBORN ERRORS OF METABOLISM PHENYLKETONURIA (PKU) 1:10000 CYSTIC FIBROSIS 1:2500 GALACTOSAEMIA 1:50000 CONGENITAL ADRENAL HYPERPLASIA 1:18000 CONGENITAL HYPOTHYROIDISM (TSH) 1:3000 BIOTINASE ACTIVITY 1:80000 METABOLIC DISEASES TOTAL 1:1000 1:5000 QUALITY INDEX FOR NEWBORN SCREENING PROGRAMME The total assessment of the Newborn Screening Programme by the use of specific statistical data: Sample Collection Results Report 2 d - 6 th day Sensitivity 83.33% Specificity 99.68% Prevalence 1:2897 False-Positive Percentage 0.32% 2 4 days from sample arriving to the Lab 9
10 INBORN ERRORS OF METABOLISM (IEM) DETECTED BY OUR NEWBORN PROGRAMME 1 Medium Chain Acyl Coa Dehydrogenase Deficiency 28 2 Long Chain 3 Hydroxy Acyl CoA Dehydrogenase Deficiency 29 Malonyl CoA Decarboxylase Deficiency (Malonic Acidemia) 2 Methyl 3 Hydroxybutyryl CoA Dehydrogenase Deficiency 3 Trifunctional Protein Deficiency 30 Ethylmalonic Encephalopathy 4 Very Long Chain AcylCoA Dehydrogenase Deficiency 31 Formiminoglutamic Aciduria 5 Short Chain AcylCoA Dehydrogenase Deficiency 32 Biopterin Biosynthesis Defects 6 Carnitine Palmitoyl Tranferase Deficiency Type I 33 Biopterin Regeneration Defects 7 Carnitine Palmitoyl Transferase Deficiency Type II 34 Hyperphenylalaninemia 8 Glutaryl CoA Dehydrogenase Deficiency 35 Phenylketonuria (PKU) 9 2,4 Dienoyl CoA Reductase Deficiency 36 Argininemia 10 Carnitine/Acyl Carnitine Translocase Deficiency 37 Arginino Succinic Aciduria (ASA Lyase Deficiency) 11 Carnitine Uptake Defect 38 Carbamoylphosphate Synthetase Deficiency 12 Short Chain Hydroxy AcylCoA Dehydrogenase Deficiency 39 Ornithine Transcarbamylase Deficiency 13 Medium Chain Ketoacyl CoA Thiolase Deficiency 40 Citrullinemia Type I 14 3 Hydroxy 3 MethylGlutaryl CoA Lyase Deficiency 41 Citrullinemia Type II 15 Glutaryl CoA Dehydrogenase Deficiency Type I 42 Homocystinuria 16 Isobutyryl CoA Dehydrogenase Deficiency 43 Methionine Adenosyltransferase (MAT I/III) Deficiency 17 Isovaleryl CoA Dehydrogenase Deficiency 44 Maple Syrup Urine Disease (MSUD) 18 2 Methylbutyryl CoA Dehydrogenase Deficiency 45 MTHFR 19 3 Methylcrotonyl CoA Carboxylase Deficiency 46 Tyrosinemia Type I 20 3 Methylglutaconyl CoA Hydratase Deficiency 47 Tyrosinemia Type II 21 Methylmalonyl CoA mutase(0,+) Deficiency 48 Tyrosinemia Type III 22 Adenosyl Cobalamin Synthesis Defects (CblA,B) 49 Transient neonatal Tyrosinemia 23 Methylmalonic Acidemia and Homocystinuria(CblC,D) 50 Biotinase activity 24 Maternal Vitamin B12 Deficiency 51 Galactosemia 25 Mitochondrial AcetoacetylCoA Thiolase Deficiency 52 Congenital Hypothyroidism (TSH) 26 Propionyl CoA Carboxylase Deficiency(Proprionic Acedemia) 53 Cystic Fibrosis 27 Holocarboxylase Synthetase Deficiency 54 G6PD Deficiency 10
11 STEPS FOR SPECIMEN COLLECTION AND SAMPLING PROCEDURE 1. Fill out the demographics of the card. 2. Clean the heel of the baby with alcohol prep, and let it air dry. 3. Puncture heel at the sciagraphic area. 4. Wipe out the first blood drop with sterile gauze. 5. Allow a free blood flow with a gentle squeeze of the area. 6. Allow blood drops onto the circles or lightly touch filter paper to large blood drop until completely fill circle. 11
12 SAMPLE PRESERVATION AND TRANSPORT STORING THE SAMPLES Blood samples are placed on the Guthrie Cards, dried for 2-3 hours at room temperature (up to 27 C). Once dried place each card separately in the specific envelope supplied. Samples can be preserved up to 15 days from collection if refrigerated or kept at (4-8 C). SHIPPING SAMPLES TO MEDILAB Every day, all envelopes with Guthrie cards are placed in a large envelope and ship to Medilab Laboratories via an international courier service, using our international account number. To arrange a courier sample collection, please call Medilab Reception at /2 or to info@medilabonline.com NOTE: Shipping costs undertaken by Medilab. 12
13 GUTHRIE CARD 13
14 CONTACT DETAILS 16, Nicodemou Mylona str Lycavittos - Nicosia, Cyprus Tel : (+357) / 2 Fax: (+357) info@medilabonline.com web: On Call Service (24hrs): (+357) Additional Contacts: Technical info & supplies: (+357) (direct), (+357) (ext. 3) Accounts Department: (+357) (direct), (+357) (ext. 5) fax: (+357) accounts@medilabonline.com 14
For Your Baby s Health Department of Health
Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your
More informationRoutine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015
Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is
More informationNEWBORN METABOLIC SCREEN, MINNESOTA
Lab Dept: Test Name: Chemistry NEWBORN METABOLIC SCREEN, MINNESOTA General Information Lab Order Codes: Synonyms: CPT Codes: Test Includes: PKUN Newborn Screen for Hyopothyroidism, Phenylketonuria (PKU),
More informationPositive Newborn Screens: What do you do next?
Positive Newborn Screens: What do you do next? James B. Gibson, MD, Ph.D. Biochemical Geneticist at Specially for Children Clinical Associate Professor of Pediatrics UTHSCSA Carla R. Scott, MD Pediatric
More informationHA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up
HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up Dr. Josephine Chong Clinical Professional Consultant Centre of Inborn Errors
More informationNewborn Screening in Manitoba. Information for Health Care Providers
Newborn Screening in Manitoba Information for Health Care Providers Newborn screening: a healthy start leads to a healthier life Health care professionals have provided newborn screening for phenylketonuria
More informationOverview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy
Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Alan R. Fleischman, M.D. Senior Vice President and Medical Director Chair, Federal Advisory Committee,
More informationNewborn Screening in Washington State Saving lives with a simple blood spot
Newborn Screening in Washington State Saving lives with a simple blood spot Ashleigh Ragsdale, MPH Gauri Gupta, MScPH Objectives Newborn Screening Overview Process and Law Completing Collection Cards Video
More informationNewborn Screening: Focus on Treatment
Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public
More informationNEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School
University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Answers for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation
More informationAttachment 1. Newborn Screening Program Description
Attachment 1 Newborn Screening Program Description The core mission of Texas Newborn Screening Program is to save children s lives through the early detection of life-threatening disorders. 34 Newborn
More informationMost common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Newborn Screening Examination parameters: TSH-neonatal (hypothyreosis), 17-OH progesterone (AGS), galactose (galactosemia), galactose-uridyl transferase (galacto semia), biotinidase (biotinidase ), phenylalanine
More informationMISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES
NEWBORN SCREENING Protecting your newborn MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES [ 1 ] NEWBORN SCREENING [ 2 ] FREQUENTLY ASKED QUESTIONS [ 4 ] DISORDERS INCLUDED IN NEWBORN SCREENING [ 12 ]
More informationNewborn Bloodspot Screening Information for parents
Newborn Bloodspot Screening Information for parents You will be offered a bloodspot screening test for your newborn baby for several rare but serious conditions. The sample for this test is usually taken
More informationNewborn Bloodspot Screening Information for parents
Newborn Bloodspot Screening Information for parents You will be offered a bloodspot screening test for your newborn baby for several rare but serious conditions. The sample for this test is usually taken
More information(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;
Ga. Comp. R. & Regs. r. 511-5-5-.02 Definitions Rule 511-5-5-.02. Definitions (a) "Abnormal test result" is a test result from blood testing or physiologic monitoring that is outside the screening limits
More informationNEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES
NEWBORN SCREENING health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES Table of Contents NEWBORN SCREENING...1 FREQUENTLY ASKED QUESTIONS...2 DISORDERS INCLUDED IN NEWBORN SCREENING...4
More informationTIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN
TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN Susan Tanksley, PhD May 19, 2015 TIMELINESS - BACKGROUND In order to effectively
More informationNewborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)
Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of
More informationConsiderations in Choosing Screening Conditions: One (US) Approach
22 Plenary Considerations in Choosing Screening Conditions: One (US) Approach Bradford L Therrell Jr, 1,2 MS, PhD Abstract The lack of a national policy on newborn screening (NBS) in the United States
More informationNewborn bloodspot testing
Policy HUMAN GENETICS SOCIETY OF AUSTRALASIA ARBN. 076 130 937 (Incorporated Under the Associations Incorporation Act) The liability of members is limited RACP, 145 Macquarie Street, Sydney NSW 2000, Australia
More information[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995
RULES AND REGULATIONS PERTAINING TO THE NEWBORN METABOLIC, ENDOCRINE, AND HEMOGLOBINOPATHY SCREENING PROGRAM AND THE NEWBORN HEARING LOSS SCREENING PROGRAM [R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
MEDICAL FOODS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are
More informationNewborn Bloodspot Screening (NBS) Training for Health Visitors. December 2017
Newborn Bloodspot Screening (NBS) Training for Health Visitors www.newbornbloodspotscreening.wales.nhs.uk December 2017 Aims To enable you to gain a clear understanding of the following: Aim and rationale
More informationA Guide for Prenatal Educators
A Guide for Prenatal Educators Why Teach Newborn Screening This booklet is designed to make it easy for you, a prenatal educator, to effectively inform expectant parents about newborn screening. All of
More informationTitle: Assessing Recommendations Related To Timeliness of Newborn Screening
Title: Assessing Recommendations Related To Timeliness of Newborn Screening Purpose: In January 2014, the Secretary s Discretionary Advisory Committee on Heritable Diseases on Newborns and Children (Committee)
More informationBeyond the case for NBS in South Africa. Chris Vorster 28/05/2016
Beyond the case for NBS in South Africa Chris Vorster 28/05/2016 The case for NBS in SA Economic justification Cost Utility analysis = Cost/QALY GDP/Capita Immediate implementation (WHO) Political justification
More informationDiagnose a broad range of metabolic disorders with a single test, Global MAPS
PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds
More informationNEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School
University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Information for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation
More informationScreening Newborns for Congenital Disorders
Screening Newborns for Congenital Disorders Gary L. Hoffman, BS; Ronald H. Laessig, PhD ABSTRACT The Newborn Screening Laboratory at the Wisconsin State Laboratory of Hygiene (WSLH) tests all newborn babies
More informationInformation for health professionals
Changes to the Newborn Bloodspot Screening Policy for Congenital Hypothyroidism (CHT) in Preterm Babies A UK policy change has been agreed that will mean changes to: which preterm babies require second
More informationNEWBORN SCREENING PRENATAL CURRICULUM
NEWBORN SCREENING PRENATAL CURRICULUM GOAL 1: Explain why newborn screening is important GOAL 2: How newborn screening is performed GOAL 3: The newborn screening test results GOAL 4: Follow-up to newborn
More informationFurther expansion of the neonatal screening panel in the Netherlands
Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1
More informationNewborn Screening: What s New?
Newborn Screening: What s New? Patricia M. Jones, PhD (Department of Pathology, University of Texas Southwestern Medical Center and Children s Medical Center of Dallas, Dallas, TX) DOI: 10.1309/LMOOXWVPSM5FC3B6
More informationNewborn Screening: Train the Trainer PPT Questions
Newborn Screening: Train the Trainer PPT Questions Bloodspot Screening Purpose 1. How many possible hidden disorders does the Oklahoma Newborn Screening Program screen for? A. >10 B. >20 C. >30 D. >40
More informationThe Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot
The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State Caroline T. Nucup-Villaruz, MD Primary Author NBS Consultant - Disorder FU Santosh Shaunak Co-Author & Presenter Laboratory
More informationNEWBORN SCREENING IN JAPAN
NEWBORN SCREENING IN JAPAN Kikurnaro Aoki KagawaNutrition University, Saitama, Japan Abstract. In the 19701s, the government began to take steps for the treatment of congenital diseases. Mass newborn screening
More informationNewborn Screening & Methods for Diagnosing Inborn Errors of Metabolism
Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism Patricia Jones, PhD DABCC FACB UT Southwestern Medical Center Children s Medical Center Dallas, Texas Learning Objectives Justify
More informationState of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report
State of the Art of Rare Disease Activities in EU Member States and Other European Countries Slovak Republic Report Definition of a Rare Disease The Slovak Republic has adopted the European Commission
More informationProposal for EXPANDED NEWBORN SCREENING
Proposal for EXPANDED NEWBORN SCREENING Tel:+971-4-4503875 Fax:+971-4-4503874 DuBiotech, P.O.Box 212671Dubai, UAE. Email: info@easternbiotech.com www.easternbiotech.com Winner of Dubai SME100 Ranked #19
More informationThe spectrum and outcome of the. neonates with inborn errors of. metabolism at a tertiary care hospital
The spectrum and outcome of the neonates with inborn errors of metabolism at a tertiary care hospital Dr. Sevim Ünal Neonatology Division, Ankara Children s Hematology Oncology Research Hospital, Ankara,
More informationNewborn Metabolic Screening Programme Annual Report
Newborn Metabolic Screening Programme Annual Report January to December 2015 Disclaimer This publication reports on information provided to the Ministry of Health by the Auckland District Health Board.
More informationNewborn Screening: Blood Spot Disorders
Newborn Screening: Blood Spot Disorders Arizona s Newborn Screening Program Program Overview Panel of Disorders Disorder Descriptions Program Components Hospitals ADHS Lab ADHS Follow-up ADHS Billing Medical
More informationFor the Ongoing Management of Babies under 1 year old.
Pathway Author: Nicy Turney, Senior Nurse Professional Lead, Health Visiting 19.06.17 For the Ongoing Management of Babies under 1 year old. Check Health Records (CHR) to undertake daily checks to identify:
More informationMedical Foods for Inborn Errors of Metabolism
Medical Foods for Inborn Errors of Metabolism Policy Number: Original Effective Date: MM.02.014 02/18/2000 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 08/23/2013 Section: Medicine Place(s)
More informationNewborn Metabolic Screening Programme
Newborn Metabolic Screening Programme Annual Report January to December 2017 Released 2018 health.govt.nz Disclaimer This publication reports on information provided to the Ministry of Health by the Auckland
More informationNewborn Metabolic Screening Programme. Annual Report
Newborn Metabolic Screening Programme Annual Report January to December 2016 1 Disclaimer This publication reports on information provided to the Ministry of Health by the Auckland District Health Board.
More informationComprehensive cost-utility analysis of newborn screening strategies Carroll A E, Downs S M
Comprehensive cost-utility analysis of newborn screening strategies Carroll A E, Downs S M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS
More informationSelective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain.
Selective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain. Jamal Golbahar PhD Associate Professor of Molecular Medicine, Department of Molecular Medicine,
More informationAssessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory
Assessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory Bao Yang MPH Candidate Background The Wisconsin Newborn Screening (NBS) Laboratory screens 70,000 babies
More informationInformation for health professionals
Introduction of a new screening test for newborn babies in Wales Newborn bloodspot screening for Medium chain acyl-coa dehydrogenase deficiency (MCADD) Newborn bloodspot screening for MCADD is being introduced
More informationAssessing Mothers Knowledge of the Wisconsin Newborn Screening Program. Sara Wolfgram UW Master of Public Health Symposium August 11, 2006
Assessing Mothers Knowledge of the Wisconsin Newborn Screening Program Sara Wolfgram UW Master of Public Health Symposium August 11, 2006 Background Wisconsin Newborn Screening (NBS): Began in 1965 Heel
More informationINBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides
INBORN ERRORS OF METABOLISM (IEM) 1 OBJECTIVES What are IEMs? Categories When to suspect? History and clinical pointers Metabolic presentation Differential diagnosis Emergency and long term management
More informationNewborn Screening. Helping babies start life healthy. Minnesota Newborn Screening Program
Newborn Screening Helping babies start life healthy Minnesota Newborn Screening Program What is newborn screening? Newborn screening is a set of three tests that check babies for serious, rare conditions.
More informationAnnual Report Calendar Year 2015
Annual Report Calendar Year 2015 Page 1 of 19 Contents 1. SAMPLE VOLUMES IN 2015...3 1.1 SCREENING SAMPLES...3 1.1.1 INFANTS SCREENED...3 1.1.2 DECLINED/DEFERRED TESTING...4 1.1.3 MISSED SCREENS...5 1.2
More informationNewborn Genetic Testing & Surveillance System
Georgia Newborn Genetic Testing & Surveillance System State GA Statute/ Rule STATUTE: Chapter 1 Chapter 2 Chapter 12 Title 33 Chapter 54 RULE: 290-5-.02 and 290-5- 24 Language Specific to Genetic Testing
More informationSlide 1: Newborn Bloodspot Screening for Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
Slide 1: Newborn Bloodspot Screening for Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD) The information has been produced with thanks to the NHS Newborn Blood Spot Screening Programme. 1 Slide
More informationMetabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius
Metabolic Changes in ASD Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius 12 patients 3 Autism: Ages 3/3/3.7 3 PDD: Ages 3/3/6 3 Asperger: Ages 6/7/15.1 3 Speech delay and Sensory Problems (SHL):
More informationMost common metabolic disorders in childhood. Neonatal screening and diagnostic approach to the. Inborn errors of metabolism (IEM)
Department of Pediatrics and Developmental Disorders Medical University of Bialystok Most common metabolic disorders in childhood. Neonatal screening and diagnostic approach to the inborn errors of metabolism
More informationPilot Study of Newborn Screening (NBS) for Inborn Errors of Metabolism (IEM) in Collaboration with Department of Health and Hospital Authority
HA Convention 2017 Service Enhancement Presentation Healthcare Advances, Research and Innovations Pilot Study of Newborn Screening (NBS) for Inborn Errors of Metabolism (IEM) in Collaboration with Department
More informationCommunity Genetics. Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital
Community Genetics Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital Training Course in Sexual and Reproductive Health Research Geneva 2011 Definition of Community Genetics
More informationNeonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry: Experience of the Pilot Study in Andhra Pradesh, India
Indian J Pediatr (August 2011) 78(8):953 960 DOI 10.1007/s12098-011-0398-9 ORIGINAL ARTICLE Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry: Experience of the Pilot Study
More informationInborn Errors of Metabolism. Metabolic Pathway. Digestion and Fasting. How is Expanded Newborn Screening Different? MS/MS. The body is a factory.
Inborn Errors of Metabolism The body is a factory. Inborn errors of metabolism are rare genetic disorders in which the body cannot properly turn food into energy. The disorders are usually caused by defects
More informationBiochemical Genetics
Biochemical Genetics Laboratory Handbook 20010/11 Block 20 St James s Hospital Beckett Street Leeds LS9 7TF Introduction The Biochemical Genetics service is comprised of two regional laboratories, screening
More informationEarly Intervention: The Importance of Newborn Screening
Early Intervention: The Importance of Newborn Screening July is the 50 th anniversary of screening newborns for genetic, endocrine and metabolic diseases. Missouri Kids Count is celebrating one of our
More informationOrganic Acid Disorders
Genetic Fact Sheets for Parents Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues
More informationOrganic Acid Disorders
Genetic Fact Sheets for Parents Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues
More informationReliable. results. efficiently. for CH, galactosemia, CAH and CF screening
GSP Neonatal assays for CH, galactosemia, CAH and CF screening Reliable results efficiently GSP Neonatal kits DELFIA or enzyme-based fluorescence assays GSP is the new, automated neonatal screening system
More informationAnnual Report Calendar Year 2014
Annual Report Calendar Year 2014 1 Contents 1. SAMPLE VOLUMES IN 2014...4 1.1 SCREENING SAMPLES...4 1.1.1 INFANTS SCREENED...4 1.1.2 DECLINED/DEFERRED TESTING...5 1.1.3 MISSED SCREENS...6 1.2 NON-SCREENING
More informationWHO Growth Grids/ 2012 Risk Changes. Diane Traver Joyce Bryant
WHO Growth Grids/ 2012 Risk Changes Diane Traver Joyce Bryant Overview CDC vs WHO Growth Charts- Why Change? Transition from
More informationSo Much More Than The PKU Test
Newborn Metabolic Screening So Much More Than The PKU Test Sarah Viall, MSN, PPCNP BC Newborn Screening Program Coordinator Division of Genetics & Metabolism Conflicts of Interest I have no conflicts of
More informationNewborn screening project at departments of genetics and endocrinology SGPGIMS, Lucknow
Newborn screening project at departments of genetics and endocrinology SGPGIMS, Lucknow Population based newborn screening (NBS) is being carried out in developed nations for the last 40 years. It aims
More informationSUMMARY THE RELEVANCE OF THE NEONATAL URINE SCREENING FOR INBORN ERRORS OF METABOLISM PERFORMED IN QUÉBEC. Introduction
SUMMARY THE RELEVANCE OF THE NEONATAL URINE SCREENING FOR INBORN ERRORS OF METABOLISM PERFORMED IN QUÉBEC Introduction Screening newborns for a number of hereditary diseases is common practice throughout
More informationHealth and Wellness for all Arizonans. azdhs.gov
To identify newborns with certain, rare disorders and assist families of affected infants so that they receive appropriate and timely treatment to prevent or delay serious medical problems. To identify
More informationNewborn Screening Manual
Newborn Screening Manual A GUIDE FOR NEWBORN CARE PROVIDERS N ONATAL Newborn Screening Manual: A guide for newborn care providers This manual was created by Newborn Screening Ontario (NSO) as a comprehensive
More informationOVERVIEW M ET AB OL IS M OF FR EE FA TT Y AC ID S
LIPOLYSIS LIPOLYSIS OVERVIEW CATABOLISM OF FREE FATTY ACIDS Nonesterified fatty acids Source:- (a) breakdown of TAG in adipose tissue (b) action of Lipoprotein lipase on plasma TAG Combined with Albumin
More informationNATIONAL PROTOCOLS. Newborn Bloodspot Screening Programme. Release: Version 1.0. Date: Feb 2017
keppåçíä~åç=påêééåáåö=mêçöê~ããéë=j=mêéöå~ååó=~åç=kéïäçêå=påêééåáåö= NATIONAL PROTOCOLS Programme: Newborn Bloodspot Screening Programme Release: Version 1.0 Date: Feb 2017 CONTENTS Foreword 4 Key points
More informationJoshua Hellmann Foundation Newborn Metabolic Screening Program Clinical Protocol
Joshua Hellmann Foundation Newborn Metabolic Screening Program Clinical Protocol Centre of Inborn Errors of Metabolism The Chinese University of Hong Kong Version 7 Effective Date: 15 th February 2016
More informationLauren E. Cipriano, BSc, BA, 1 C. Anthony Rupar, PhD, 2 Gregory S. Zaric, PhD 1. Introduction
Blackwell Publishing IncMalden, USAVHEValue in Health1098-30152006 Blackwell Publishing20071028397Original ArticleCost-Effectiveness of Newborn ScreeningCipriano et al. Volume 10 Number 2 2007 VALUE IN
More informationOrganic Acid Disorders
Genetic Fact Sheets for Parents Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues
More informationInborn Errors of Metabolism From Neonatal Screening to Metabolic Pathways
19 May 2015 Hospital Authority Convention 2015 Corporate Scholarship Presentation II Paediatric Services Inborn Errors of Metabolism From Neonatal Screening to Metabolic Pathways Dr Grace Poon Associate
More informationUK Newborn Screening for X-ALD - progress from a lab perspective
UK Newborn Screening for X-ALD - progress from a lab perspective Mrs. Leila Cornes Senior Clinical Scientist, Newborn Screening Southmead Hospital, Bristol May 2016 C26:0-lysoPC C26:0-lysophosphatidylcholine
More informationChapter 4 : Newborn Screening
Chapter 4 : Newborn Screening Almost every child born in the United States undergoes state-mandated newborn screening. For each state, a small blood sample ( heel stick ) is collected from each newborn
More informationHealth Chapter ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH BUREAU OF FAMILY HEALTH SERVICES ADMINISTRATIVE CODE
ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH BUREAU OF FAMILY HEALTH SERVICES ADMINISTRATIVE CODE CHAPTER 420-10-1 CARE AND TREATMENT OF INFANTS IDENTIFIED THROUGH THE NEWBORN SCREENING
More informationScreening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry
The new england journal of medicine original article Screening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry Bridget Wilcken, M.B., Ch.B., Veronica Wiley, Ph.D., Judith Hammond,
More informationWashington State Newborn Screening
Washington State Newborn Screening SAVING LIVES WITH A SIMPLE BLOOD SPOT WA State DOH 1 Washington State Numbers 1 2 173,000 specimens 90,000 newborns 2-screen state NBS 17 lab staff 5 disorder FU staff
More informationGreen Amber Red Assurance Level
A re-audit of the turnaround time of samples for the Sickle Cell and Thalassaemia Newborn Screening Programme, in the Manchester Newborn Screening Laboratory Clinical Audit Report May 2014 Clinical Audit
More informationAtlas of Genetics and Cytogenetics in Oncology and Haematology
Atlas of Genetics and Cytogenetics in Oncology and Haematology Neonatal Screening I - INTRODUCTION 1- Neonatal screening for a metabolic disease must address a frequent pathology for which there is an
More informationNEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM OUR EXPERIENCE AT CABRI, GULF MEDICAL UNIVERSITY
GMJ GULF MEDICAL JOURNAL ORAL PROCEEDINGS NEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM OUR EXPERIENCE AT CABRI, GULF MEDICAL UNIVERSITY I.A. Shaafie 1 *, A.D. Vijay Raju 2, P.K. Menon 3 1Division
More informationBIOTIN (BIOTINIDASE) DEFICIENCY Marc E. Tischler, PhD; University of Arizona
BIOTIN (BIOTINIDASE) DEFICIENCY Marc E. Tischler, PhD; University of Arizona BIOTIN (BIOTINIDASE) DEFICIENCY biotin in the body is recycled by its removal from carboxylase enzymes to which it is attached
More informationFatty Acid Oxidation Disorders
Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social
More informationWhat s new in newborn screening?
PERSPECTIVE What s new in newborn screening? Bradford L Therrell Jr 1,2, Colleen Buechner 1,2, Michele A Lloyd-Puryear 3,4, Peter C van Dyck 3,5 & Marie Y Mann 3,6 Author for correspondence 1 National
More informationCYSTIC FIBROSIS. The condition:
CYSTIC FIBROSIS Both antenatal and neonatal screening for CF have been considered. Antenatal screening aims to identify fetuses affected by CF so that parents can be offered an informed choice as to whether
More informationState of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Portugal Report
State of the Art of Rare Disease - Activities in EU Member States and Other European Countries Definition of a Rare Disease Portugal Report Portugal has adopted the European Commission definition of a
More informationNewborn Blood Spot Screening Service. Information for Users
Newborn Blood Spot Screening Service Information for Users Newborn Blood Spot user Handbook v1 Page 1 14/07/2016 Content s Laboratory Information... 3 The Service... 3 Laboratory Mission Statement... 3
More informationOrganic Acid Disorders
Genetic Fact Sheets for Parents Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues
More informationPKU (Phenylketonuria) Serum HPLC Analysis Kit User Manual
Page 1 / 20 PKU (Phenylketonuria) Serum HPLC Analysis Kit User Manual ZV-4003-0200-10 200 2-8 C Page 2 / 20 Table of Contents 1. INTENDED USE... 3 2. SUMMARY AND EXPLANATION... 3 3. TEST PRINCIPLE... 3
More informationNewborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet
Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet Website:www.tipn.org.tw Telephone:(02)85962050 Ext. 401-403 Service line:(02)85962065 Fax:(02)85962067
More informationCollection of Dried Blood Spots from Infants for Diagnosis of HIV by DNA PCR. MOH Regional Trainings March 2013
Collection of Dried Blood Spots from Infants for Diagnosis of HIV by DNA MOH Regional Trainings March 2013 Outline Introduce DBS testing Rationale Testing algorithm Sample collection, storage and transportation
More informationFatty Acid Oxidation Disorders Organic Acid Disorders
Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial,
More information